Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
“An insulin pen, which contains a cartridge that holds the insulin, is a convenient way for many people to carry and use ...
Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...
We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
Krista Llewellyn was diagnosed with Type 1 diabetes at 12 years old, but she hasn’t let managing her blood sugar levels stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback